“This Summit is a very important and timely gathering for leading biopharma strategists and disruptors to get together to discuss the impact AI will have on our industry. It’s essential we have in-depth conversations now about the problems AI is best suited to solve and how to take advantage of new AI technologies. I am thrilled to be Chairing this industry-leading event.” — Harry Glorikian, Summit Chairman

The place for real conversation with biopharma industry leaders using AI

The AI Applications in Biopharma Summit is the only event to convene key strategic biopharma stakeholders and data driven disruptors to discuss their experiences, obstacles, opportunities for partnerships, and strategies they have used to implement AI technologies in the discovery and drug development process.

Interest in AI driven technologies is growing fast among leaders in the biopharma industry. Over 40 industry peers discussed the practical steps for prioritizing and implementing AI technologies to achieve the greatest impact and ROI. The event enabled industry leaders to find partners to help keep the AI in Biopharma movement growing and moving forward.

Make Valuable Connections

Find Out What Questions To Ask

You have been asked to implement AI technology, but where do you start? Gain a better understanding of the questions you need to ask to impact projects and operational efficiency to lower costs and ultimately improve outcomes.

Meet The CEOs

With the CEOs of BERG, Insilico Medicine, twoXAR, Numerate, Cloud Pharmaceuticals, ReviveMed and more sharing their experiences, the AI Applications Summit is the ultimate meeting of biopharma and technology.

Summit at a Glance

AI in Research and Development: Hear how to harness the power of AI to generate novel drug candidates, unlock ADME/Tox obstacles, and decrease the risk profile for regulatory decision-making.

AI in Clinical Trials: Discover how AI can be used to influence the design and optimization of clinical trials and the recruitment and retention of patients and how getting the corporate culture right will improve business outcome conversations and results.

Moving from the ‘Science of AI’ to ‘Using AI Tools in Pharma Science’: Understand from Chief Data Officers why data is the new key asset and explore real world evidence and AI and how we can take the next steps forward to start directly impacting care.